{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:26Z","timestamp":1761895586974},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T00:00:00Z","timestamp":1351900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00198-012-2198-0","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T17:09:05Z","timestamp":1351876145000},"page":"2127-2132","source":"Crossref","is-referenced-by-count":15,"title":["Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment"],"prefix":"10.1007","volume":"24","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Makras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gkiomisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Savvides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,3]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.10.009","volume":"359","author":"DM Kretser de","year":"2012","unstructured":"de Kretser DM, O'Hehir RE, Hardy CL, Hedger MP (2012) The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol 359:101\u2013106","journal-title":"Mol Cell Endocrinol"},{"key":"2198_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-12-385961-7.00010-X","volume":"85","author":"C Payne","year":"2011","unstructured":"Payne C, King J, Hay D (2011) The role of activin\/nodal and Wnt signaling in endoderm formation. Vitam Horm 85:207\u2013216","journal-title":"Vitam Horm"},{"key":"2198_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1450225","volume":"145","author":"S Luisi","year":"2001","unstructured":"Luisi S, Florio P, Reis FM, Petraglia F (2001) Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 145:225\u2013236","journal-title":"Eur J Endocrinol"},{"key":"2198_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14310\/horm.2002.1308","volume":"10","author":"KA Toulis","year":"2011","unstructured":"Toulis KA, Anastasilakis AD, Polyzos S, Makras P (2011) Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis. Hormones (Athens) 10:174\u2013195","journal-title":"Hormones (Athens)"},{"key":"2198_CR5","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1096\/fj.07-8080com","volume":"21","author":"M Eijken","year":"2007","unstructured":"Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, van der Spek PJ, Visser JA, de Jong FH, Pols HA, van Leeuwen JP (2007) The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J 21:2949\u20132960","journal-title":"FASEB J"},{"key":"2198_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/en.143.1.74","volume":"143","author":"D Gaddy-Kurten","year":"2002","unstructured":"Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC (2002) Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74\u201383","journal-title":"Endocrinology"},{"key":"2198_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2009.07.001","volume":"310","author":"KM Nicks","year":"2009","unstructured":"Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D (2009) Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, activin and inhibin. Mol Cell Endocrinol 310:11\u201320","journal-title":"Mol Cell Endocrinol"},{"key":"2198_CR8","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1016\/S0021-9258(18)42930-4","volume":"267","author":"M Hashimoto","year":"1992","unstructured":"Hashimoto M, Shoda A, Inoue S, Yamada R, Kondo T, Sakurai T et al (1992) Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem 267:4999\u20135004","journal-title":"J Biol Chem"},{"key":"2198_CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T","volume":"75","author":"T Ikenoue","year":"1999","unstructured":"Ikenoue T, Jingushi S, Urabe K, Okazaki K, Iwamoto Y (1999) Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J Cell Biochem 75:206\u2013214","journal-title":"J Cell Biochem"},{"key":"2198_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1315.023","volume":"1038","author":"W Vale","year":"2004","unstructured":"Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S (2004) Activins and inhibins and their signaling. Ann N Y Acad Sci 1038:142\u2013147","journal-title":"Ann N Y Acad Sci"},{"key":"2198_CR11","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, Santo L, Cirstea D, Patel K, Sohani AR, Guimaraes A, Xie W, Chauhan D, Schoonmaker JA, Attar E, Churchill M, Weller E, Munshi N, Seehra J, Weissleder R, Anderson KC, Scadden DT, Raje N (2010) Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A 107:5124\u20135129","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2198_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu L, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125:247\u2013260","journal-title":"Cell"},{"key":"2198_CR13","doi-asserted-by":"crossref","unstructured":"Terpos E, Kastritis E, Christoulas D, Gkotzamanidou M, Eleutherakis-Papaiakovou E, Kanellias N, Papatheodorou A, Dimopoulos MA (2012) Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. Ann Oncol 23:2681\u20132686","DOI":"10.1093\/annonc\/mds068"},{"key":"2198_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcp.22272","volume":"225","author":"G Leto","year":"2010","unstructured":"Leto G (2010) Activin A and bone metastases. J Cell Physiol 225:302\u2013309","journal-title":"J Cell Physiol"},{"key":"2198_CR15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","volume":"46","author":"S Lotinun","year":"2010","unstructured":"Lotinun S, Pearsall RS, Davies MV, Marvell TH, Monnell TE, Ucran J, Fajardo RJ, Kumar R, Underwood KW, Seehra J, Bouxsein ML, Baron R (2010) A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. Bone 46:1082\u20131088","journal-title":"Bone"},{"key":"2198_CR16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1359\/jbmr.081208","volume":"24","author":"J Ruckle","year":"2009","unstructured":"Ruckle J, Jacobs M, Kramer W, Pearsall AE, Kumar R, Underwood KW, Seehra J, Yang Y, Condon CH, Sherman ML (2009) Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women. J Bone Miner Res 24:744\u2013752","journal-title":"J Bone Miner Res"},{"key":"2198_CR17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","volume":"346","author":"IR Reid","year":"2002","unstructured":"Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653\u2013661","journal-title":"N Engl J Med"},{"key":"2198_CR18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"2198_CR19","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1210\/jc.2010-1103","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S (2010) Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab 95:5063\u20135068","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","volume":"50","author":"GG Loots","year":"2012","unstructured":"Loots GG, Keller H, Leupin O, Murugesh D, Collette NM, Genetos DC (2012) TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer. Bone 50:663\u2013669","journal-title":"Bone"},{"key":"2198_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bbrc.2000.2075","volume":"268","author":"K Fuller","year":"2000","unstructured":"Fuller K, Bayley KE, Chambers TJ (2000) Activin A is an essential cofactor for osteoclast induction. Biochem Biophys Res Commun 268:2\u20137","journal-title":"Biochem Biophys Res Commun"},{"key":"2198_CR22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0531-5565(01)00117-6","volume":"36","author":"A Baccarelli","year":"2001","unstructured":"Baccarelli A, Morpurgo PS, Corsi A, Vaghi I, Fanelli M, Cremonesi G, Vaninetti S, Beck-Peccoz P, Spada A (2001) Activin A serum levels and aging of the pituitary-gonadal axis: a cross-sectional study in middle-aged and elderly healthy subjects. Exp Gerontol 36:1403\u20131412","journal-title":"Exp Gerontol"},{"key":"2198_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14310\/horm.2002.1303","volume":"10","author":"PN Singhellakis","year":"2011","unstructured":"Singhellakis PN, Malandrinou FC, Psarrou CJ, Danelli AM, Tsalavoutas SD, Constandellou ES (2011) Vitamin D deficiency in white, apparently healthy, free-living adults in a temperate region. Hormones (Athens) 10:131\u2013143","journal-title":"Hormones (Athens)"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2198-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2198-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:48:05Z","timestamp":1643575685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2198-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,3]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2198-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,3]]}}}